-
TotalVibeSegmentator: Full Torso Segmentation for the NAKO and UK Biobank in Volumetric Interpolated Breath-hold Examination Body Images
Authors:
Robert Graf,
Paul-Sören Platzek,
Evamaria Olga Riedel,
Constanze Ramschütz,
Sophie Starck,
Hendrik Kristian Möller,
Matan Atad,
Henry Völzke,
Robin Bülow,
Carsten Oliver Schmidt,
Julia Rüdebusch,
Matthias Jung,
Marco Reisert,
Jakob Weiss,
Maximilian Löffler,
Fabian Bamberg,
Bene Wiestler,
Johannes C. Paetzold,
Daniel Rueckert,
Jan Stefan Kirschke
Abstract:
Objectives: To present a publicly available torso segmentation network for large epidemiology datasets on volumetric interpolated breath-hold examination (VIBE) images. Materials & Methods: We extracted preliminary segmentations from TotalSegmentator, spine, and body composition networks for VIBE images, then improved them iteratively and retrained a nnUNet network. Using subsets of NAKO (85 subje…
▽ More
Objectives: To present a publicly available torso segmentation network for large epidemiology datasets on volumetric interpolated breath-hold examination (VIBE) images. Materials & Methods: We extracted preliminary segmentations from TotalSegmentator, spine, and body composition networks for VIBE images, then improved them iteratively and retrained a nnUNet network. Using subsets of NAKO (85 subjects) and UK Biobank (16 subjects), we evaluated with Dice-score on a holdout set (12 subjects) and existing organ segmentation approach (1000 subjects), generating 71 semantic segmentation types for VIBE images. We provide an additional network for the vertebra segments 22 individual vertebra types. Results: We achieved an average Dice score of 0.89 +- 0.07 overall 71 segmentation labels. We scored > 0.90 Dice-score on the abdominal organs except for the pancreas with a Dice of 0.70. Conclusion: Our work offers a detailed and refined publicly available full torso segmentation on VIBE images.
△ Less
Submitted 31 May, 2024;
originally announced June 2024.
-
DenseNet and Support Vector Machine classifications of major depressive disorder using vertex-wise cortical features
Authors:
Vladimir Belov,
Tracy Erwin-Grabner,
Ling-Li Zeng,
Christopher R. K. Ching,
Andre Aleman,
Alyssa R. Amod,
Zeynep Basgoze,
Francesco Benedetti,
Bianca Besteher,
Katharina Brosch,
Robin Bülow,
Romain Colle,
Colm G. Connolly,
Emmanuelle Corruble,
Baptiste Couvy-Duchesne,
Kathryn Cullen,
Udo Dannlowski,
Christopher G. Davey,
Annemiek Dols,
Jan Ernsting,
Jennifer W. Evans,
Lukas Fisch,
Paola Fuentes-Claramonte,
Ali Saffet Gonul,
Ian H. Gotlib
, et al. (63 additional authors not shown)
Abstract:
Major depressive disorder (MDD) is a complex psychiatric disorder that affects the lives of hundreds of millions of individuals around the globe. Even today, researchers debate if morphological alterations in the brain are linked to MDD, likely due to the heterogeneity of this disorder. The application of deep learning tools to neuroimaging data, capable of capturing complex non-linear patterns, h…
▽ More
Major depressive disorder (MDD) is a complex psychiatric disorder that affects the lives of hundreds of millions of individuals around the globe. Even today, researchers debate if morphological alterations in the brain are linked to MDD, likely due to the heterogeneity of this disorder. The application of deep learning tools to neuroimaging data, capable of capturing complex non-linear patterns, has the potential to provide diagnostic and predictive biomarkers for MDD. However, previous attempts to demarcate MDD patients and healthy controls (HC) based on segmented cortical features via linear machine learning approaches have reported low accuracies. In this study, we used globally representative data from the ENIGMA-MDD working group containing an extensive sample of people with MDD (N=2,772) and HC (N=4,240), which allows a comprehensive analysis with generalizable results. Based on the hypothesis that integration of vertex-wise cortical features can improve classification performance, we evaluated the classification of a DenseNet and a Support Vector Machine (SVM), with the expectation that the former would outperform the latter. As we analyzed a multi-site sample, we additionally applied the ComBat harmonization tool to remove potential nuisance effects of site. We found that both classifiers exhibited close to chance performance (balanced accuracy DenseNet: 51%; SVM: 53%), when estimated on unseen sites. Slightly higher classification performance (balanced accuracy DenseNet: 58%; SVM: 55%) was found when the cross-validation folds contained subjects from all sites, indicating site effect. In conclusion, the integration of vertex-wise morphometric features and the use of the non-linear classifier did not lead to the differentiability between MDD and HC. Our results support the notion that MDD classification on this combination of features and classifiers is unfeasible.
△ Less
Submitted 18 November, 2023;
originally announced November 2023.
-
Recommendations on test datasets for evaluating AI solutions in pathology
Authors:
André Homeyer,
Christian Geißler,
Lars Ole Schwen,
Falk Zakrzewski,
Theodore Evans,
Klaus Strohmenger,
Max Westphal,
Roman David Bülow,
Michaela Kargl,
Aray Karjauv,
Isidre Munné-Bertran,
Carl Orge Retzlaff,
Adrià Romero-López,
Tomasz Sołtysiński,
Markus Plass,
Rita Carvalho,
Peter Steinbach,
Yu-Chia Lan,
Nassim Bouteldja,
David Haber,
Mateo Rojas-Carulla,
Alireza Vafaei Sadr,
Matthias Kraft,
Daniel Krüger,
Rutger Fick
, et al. (5 additional authors not shown)
Abstract:
Artificial intelligence (AI) solutions that automatically extract information from digital histology images have shown great promise for improving pathological diagnosis. Prior to routine use, it is important to evaluate their predictive performance and obtain regulatory approval. This assessment requires appropriate test datasets. However, compiling such datasets is challenging and specific recom…
▽ More
Artificial intelligence (AI) solutions that automatically extract information from digital histology images have shown great promise for improving pathological diagnosis. Prior to routine use, it is important to evaluate their predictive performance and obtain regulatory approval. This assessment requires appropriate test datasets. However, compiling such datasets is challenging and specific recommendations are missing.
A committee of various stakeholders, including commercial AI developers, pathologists, and researchers, discussed key aspects and conducted extensive literature reviews on test datasets in pathology. Here, we summarize the results and derive general recommendations for the collection of test datasets.
We address several questions: Which and how many images are needed? How to deal with low-prevalence subsets? How can potential bias be detected? How should datasets be reported? What are the regulatory requirements in different countries?
The recommendations are intended to help AI developers demonstrate the utility of their products and to help regulatory agencies and end users verify reported performance measures. Further research is needed to formulate criteria for sufficiently representative test datasets so that AI solutions can operate with less user intervention and better support diagnostic workflows in the future.
△ Less
Submitted 21 April, 2022;
originally announced April 2022.
-
An Uncertainty-Aware, Shareable and Transparent Neural Network Architecture for Brain-Age Modeling
Authors:
Tim Hahn,
Jan Ernsting,
Nils R. Winter,
Vincent Holstein,
Ramona Leenings,
Marie Beisemann,
Lukas Fisch,
Kelvin Sarink,
Daniel Emden,
Nils Opel,
Ronny Redlich,
Jonathan Repple,
Dominik Grotegerd,
Susanne Meinert,
Jochen G. Hirsch,
Thoralf Niendorf,
Beate Endemann,
Fabian Bamberg,
Thomas Kröncke,
Robin Bülow,
Henry Völzke,
Oyunbileg von Stackelberg,
Ramona Felizitas Sowade,
Lale Umutlu,
Börge Schmidt
, et al. (9 additional authors not shown)
Abstract:
The deviation between chronological age and age predicted from neuroimaging data has been identified as a sensitive risk-marker of cross-disorder brain changes, growing into a cornerstone of biological age-research. However, Machine Learning models underlying the field do not consider uncertainty, thereby confounding results with training data density and variability. Also, existing models are com…
▽ More
The deviation between chronological age and age predicted from neuroimaging data has been identified as a sensitive risk-marker of cross-disorder brain changes, growing into a cornerstone of biological age-research. However, Machine Learning models underlying the field do not consider uncertainty, thereby confounding results with training data density and variability. Also, existing models are commonly based on homogeneous training sets, often not independently validated, and cannot be shared due to data protection issues. Here, we introduce an uncertainty-aware, shareable, and transparent Monte-Carlo Dropout Composite-Quantile-Regression (MCCQR) Neural Network trained on N=10,691 datasets from the German National Cohort. The MCCQR model provides robust, distribution-free uncertainty quantification in high-dimensional neuroimaging data, achieving lower error rates compared to existing models across ten recruitment centers and in three independent validation samples (N=4,004). In two examples, we demonstrate that it prevents spurious associations and increases power to detect accelerated brain-aging. We make the pre-trained model publicly available.
△ Less
Submitted 16 July, 2021;
originally announced July 2021.
-
Predicting brain-age from raw T 1 -weighted Magnetic Resonance Imaging data using 3D Convolutional Neural Networks
Authors:
Lukas Fisch,
Jan Ernsting,
Nils R. Winter,
Vincent Holstein,
Ramona Leenings,
Marie Beisemann,
Kelvin Sarink,
Daniel Emden,
Nils Opel,
Ronny Redlich,
Jonathan Repple,
Dominik Grotegerd,
Susanne Meinert,
Niklas Wulms,
Heike Minnerup,
Jochen G. Hirsch,
Thoralf Niendorf,
Beate Endemann,
Fabian Bamberg,
Thomas Kröncke,
Annette Peters,
Robin Bülow,
Henry Völzke,
Oyunbileg von Stackelberg,
Ramona Felizitas Sowade
, et al. (11 additional authors not shown)
Abstract:
Age prediction based on Magnetic Resonance Imaging (MRI) data of the brain is a biomarker to quantify the progress of brain diseases and aging. Current approaches rely on preparing the data with multiple preprocessing steps, such as registering voxels to a standardized brain atlas, which yields a significant computational overhead, hampers widespread usage and results in the predicted brain-age to…
▽ More
Age prediction based on Magnetic Resonance Imaging (MRI) data of the brain is a biomarker to quantify the progress of brain diseases and aging. Current approaches rely on preparing the data with multiple preprocessing steps, such as registering voxels to a standardized brain atlas, which yields a significant computational overhead, hampers widespread usage and results in the predicted brain-age to be sensitive to preprocessing parameters. Here we describe a 3D Convolutional Neural Network (CNN) based on the ResNet architecture being trained on raw, non-registered T$_ 1$-weighted MRI data of N=10,691 samples from the German National Cohort and additionally applied and validated in N=2,173 samples from three independent studies using transfer learning. For comparison, state-of-the-art models using preprocessed neuroimaging data are trained and validated on the same samples. The 3D CNN using raw neuroimaging data predicts age with a mean average deviation of 2.84 years, outperforming the state-of-the-art brain-age models using preprocessed data. Since our approach is invariant to preprocessing software and parameter choices, it enables faster, more robust and more accurate brain-age modeling.
△ Less
Submitted 22 March, 2021;
originally announced March 2021.
